Adams Diversified Equity Fund, Inc. Amgen Inc Transaction History

Adams Diversified Equity Fund, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $12.6 Million - $14.8 Million	-75,700 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $13.7 Million - $15.4 Million	75,700 New	75,700 $14.4 Million
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $19.2 Million - $22.4 Million	-113,300 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $19 Million - $21.6 Million	113,300	113,300 $21.1 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.